The anti-diabetic drug miglitol, an alpha-glucosidase inhibitor, was the first choice for the therapy of type II diabetes.
The anti-diabetic drug miglitol, an alpha-glucosidase inhibitor, was the first choice for the therapy of type II diabetes.
摘要米格列醇作爲一种新型α-葡糖苷酶抑制剂，能够有效治疗Ⅱ型糖尿病，幷已迅速成爲首选药物。